Replies to post #2701 on Skye Bioscience Inc (SKYE)

[Closewatcher]

Its par for the course in biotech. This raise is neccessary and will propel shares to higher valuations. If Murphy & Co wanted less money for less dilution, they wouldve raised less. This isn't their first rodeo.

In theory, and Vinpat has touched base on this, the team believes there is incredible value behind the science and IP, and therefore its only a matter of time before the market catches fire.

Progressing through Phase 2 trials for both CINP & Glaucoma sucessfully with the 20 million (key word SUCCESSFULLY), would blow the share price over $5 even with 100mill fully diluted, and then they can do another moderate raise to finish trials, or partner (which Murphy has said they prefer do to, cough cough, Allergan + Doug Ingram)

Either way, downtrend is a product of bio company tendencies, not anything that Nemus is doing wrong.

[AntonChigurh]

the 'downtrend'

However, what they do realize is a lot of dumb money does use this newest nitch charting or TA (Technical Analysis) to run a stock either up or down. To the MMs this is like taking candy from a baby. Simply they will paint the tape and use whatever tactic to affect the charting bands. Thus the public and dumb money they will have eating out of their hands. Effectively the MMs can show a strong stock growing weak by manipulating the close price in order to generate selling volume, delaying trading time to manipulate trading activities, or even stalling the ask without honoring orders to hold a stock price.

Confessions of an OTC MM

https://www.reddit.com/r/weedstocks/comments/1xydch/market_maker_speaks_out_ways_of_a_market_maker/

Reading charts is beyond my paygrade

GLTFA